Aspero Medical in the News
April 11, 2024
Aspero Medical voted People's Choice Award at the American Gastroenterological Association (AGA) Tech Summit Shark Tank competition!
Aspero Medical was selected to present at AGA's Tech Summit Shark Tank competition and was voted People's Choice Award winner for presenting the Ancora platform that is designed to revolutionize third space endoscopy with simple, practical devices that create greater access, stabilization, and retraction with exceptional ease of use.
August 31, 2023
FDA Clears Aspero Medical’s Revolutionary Pillar Balloon Enteroscopy Overtube
Aspero Medical has received clearance from the FDA to market and sell the Ancora-SB small bowel balloon overtube that incorporates the company’s patented Pillar micro-texture balloon technology. Ancora-SB is cleared for use during small bowel enteroscopy procedures.
April 2019
Destination Startup is a collaboration among leading research universities and federal laboratories across the Rocky Mountain region to showcase the best companies from our innovation ecosystem.
February 5, 2024
First Patient Enrollment into Aspero Medical NIH-Funded Study
Aspero Medical awarded a National Institutes of Health (NIH) SBIR Phase II grant to complete a double-blinded, multi-centered, randomized controlled trial (RCT) to demonstrate Ancora-SB superiority over current standards of care and assess the potential to expand indications for use.
December 29, 2020
Aspero Medical Completes Animal Clinical Study and Announces the Formation of Clinical Advisory Board
Animal clinical study finds no histopathological difference between smooth silicone balloon and Aspero's balloon with Pillar technology. Dr. Steven Edmundowicz, Chief Clinical Officer, is joined by Dr. John Vargo (Cleveland Clinic) and Dr. Andrew Ross (Virginia Mason) on Aspero's Clinical Advisory Board.
August 20, 2019
Aspero Medical connects with CU Boulder Alumni Investors in Silicon Valley Summit
July 23, 2018
Innosphere Fund Invests in University of Colorado Medical Device Start Up Company
The Innosphere Fund announces their investment in Boulder-based start-up company, Aspero Medical Corporation, a company with unique intellectual property for endoscopy procedures that was developed at the University of Colorado.
September 26, 2023
Aspero Medical has been accepted into the Biomedical Stream at Creative Destruction Lab (CDL)
Creative Destruction Lab supports the commercialization of early stage companies. Working with CDL-Vancouver, Aspero Medical will continue to enable Third-Space Endoscopy and advance flexible endoscopy intervention.